CellR4 - Page 11 of 20 - Cellular repair, replacement, regeneration, reprogramming and differentiation

CellR4 2016; 4 (3): e1920

Raw Material Specification, Insulin-like Growth Factor-1 (IGF-1) – Standard Operating Procedure of the NIH Clinical Islet Transplantation Consortium

CellR4 2016; 4 (3): e1918

Raw Material Specification, Hydrochloric Acid NF, 1 Normal – Standard Operating Procedure of the NIH Clinical Islet Transplantation Consortium

CellR4 2016; 4 (3): e1916

Raw Material Specification, Albumin Human USP, 25% Solution – Standard Operating Procedure of the NIH Clinical Islet Transplantation Consortium

CellR4 2016; 4 (3): e1914

Raw Material Specification, Cold Storage/Purification Stock Solution – Standard Operating Procedure of the NIH Clinical Islet Transplantation Consortium

CellR4 2016; 4 (3): e1912

Raw Material Specification, Phase I Solution – Standard Operating Procedure of the NIH Clinical Islet Transplantation Consortium

CellR4 2016; 4 (3): e1910

Raw Material Specification, Gradient Stock Solution – Standard Operating Procedure of the NIH Clinical Islet Transplantation Consortium

CellR4 2016; 4 (3): e1908

Raw Material Specification, Hepes Buffer, 1 M Solution, Sterile – Standard Operating Procedure of the NIH Clinical Islet Transplantation Consortium

CellR4 2016; 4 (3): e1906

Raw Material Specification, Heparin Sodium Injection, USP – Standard Operating Procedure of the NIH Clinical Islet Transplantation Consortium

CellR4 2016; 4 (3): e1904

Raw Material Specification, Hanks’ Balanced Salt Solution, Sterile – Standard Operating Procedure of the NIH Clinical Islet Transplantation Consortium

CellR4 2016; 4 (3): e1897

Raw Material Specification, CMRL 1066 Transplant Media, Contains Hepes And Without Sodium Bicarbonate – Standard Operating Procedure of the NIH Clinical Islet Transplantation Consortium

CellR4 2016; 4 (3): e1895

Raw Material Specification, CMRL 1066, Supplemented, CIT Modifications – Standard Operating Procedure of the NIH Clinical Islet Transplantation Consortium

CellR4 2016; 4 (2): e1831

Purified Human Pancreatic Islets, CIT Enzyme Solution-SERVA Enzymes Proportional Units Collagenase & Neutral Protease – Standard Operating Procedure of the NIH Clinical Islet Transplantation Consortium

CellR4 2016; 4 (2): e1822

Purified Human Pancreatic Islets, Deceased Donor Pancreas Qualification – Standard Operating Procedure of the NIH Clinical Islet Transplantation Consortium

CellR4 2016; 4 (2): e1814

Delay of the diagnosis of Graft versus host disease in an autologous stem cell transplant recipient: a case report and literature review

Oberlin K.

Department of Dermatology and Cutaneous Surgery, University of Miami School of Medicine, Miami, FL, USA
kate.oberlin@jhsmiami.org

, Ledon J.

Department of Dermatology and Cutaneous Surgery, University of Miami School of Medicine, Miami, FL, USA

, Villada G.

Department of Dermatology and Cutaneous Surgery, University of Miami School of Medicine, Miami, FL, USA

, Romanelli P.

Department of Dermatology and Cutaneous Surgery, University of Miami School of Medicine, Miami, FL, USA

CellR4 2016; 4 (2): e1810

Hypes, hopes and translational challenges on the path to cures

Ricordi C.

Diabetes Research Institute, University of Miami, Miami, FL, USA
ricordi@miami.edu

, Brunicardi F. C.

Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA

Newer
1
…
6
7
8
9
10
11
12
13
14
15
16
…
20
Older